GSK plc
GSK48.070USD
-0.340-0.70%
收盤 11/12, 16:00（美東）報價延遲15分鐘
96.76B總市值
13.41本益比TTM
關於 GSK plc 公司
GSK plc 是一家全球性生物製藥公司。該公司的部門包括商業運營和研發。該公司爲卵巢癌、子宮內膜癌和多發性骨髓瘤等患者開發抗癌藥物。其產品領域包括疫苗、特種藥物和普通藥物。該公司還專注於解決呼吸系統和炎症患者尚未滿足的治療需求。其疫苗組合包括 20 多種疫苗，可幫助保護人們免受一系列疾病和感染，包括腦膜炎、帶狀皰疹和流感等。其特種藥物部門還致力於開發用於呼吸系統疾病和艾滋病毒的藥物。其普通藥物包括用於哮喘和慢性阻塞性肺病的吸入藥物、抗生素和用於皮膚病的藥物。該公司正在推進慢性乙型肝炎和脂肪肝以及肝病以外其他治療領域的寡核苷酸療法。
GSK plc簡介
公司代碼GSK
公司名稱GSK plc
上市日期May 22, 1972
CEOMs. Deborah Waterhouse
員工數量68629
證券類型Ordinary Share
年結日May 22
公司地址980 Great West Road
城市BRENTFORD
上市交易所London Stock Exchange
國家United Kingdom
郵編TW8 9GS
電話442080475000
網址https://www.gsk.com/
公司代碼GSK
上市日期May 22, 1972
CEOMs. Deborah Waterhouse
GSK plc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Hal V. Barron, M.D.
Dr. Hal V. Barron, M.D.
Non-Executive Director
Non-Executive Director
658.41K
+0.49%
Ms. Shobie Ramakrishnan
Ms. Shobie Ramakrishnan
Chief Digital and Technology Officer
Chief Digital and Technology Officer
484.59K
+0.08%
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Senior Independent Non-Executive Director
Senior Independent Non-Executive Director
38.91K
+0.88%
Ms. Elizabeth McKee (Liz) Anderson
Ms. Elizabeth McKee (Liz) Anderson
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
+0.87%
Dr. Jeannie Lee
Dr. Jeannie Lee
Independent Non-Executive Director and Scientific & Medical Expert
Independent Non-Executive Director and Scientific & Medical Expert
1.58K
+0.83%
Dr. Harry C. (Hal) Dietz
Dr. Harry C. (Hal) Dietz
Independent Non-Executive Director, Scientific and Medical Expert
Independent Non-Executive Director, Scientific and Medical Expert
--
--
Mr. James Ford
Mr. James Ford
Senior Vice President, Group General Counsel, Legal and Compliance
Senior Vice President, Group General Counsel, Legal and Compliance
--
--
Ms. Sally Jackson
Ms. Sally Jackson
Senior Vice President - Global Communications and CEO Office
Senior Vice President - Global Communications and CEO Office
--
--
Dr. Tony Wood, Ph.D.
Dr. Tony Wood, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Ms. Julie Brown
Ms. Julie Brown
Chief Financial Officer, Executive Director
Chief Financial Officer, Executive Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Hal V. Barron, M.D.
Dr. Hal V. Barron, M.D.
Non-Executive Director
Non-Executive Director
658.41K
+0.49%
Ms. Shobie Ramakrishnan
Ms. Shobie Ramakrishnan
Chief Digital and Technology Officer
Chief Digital and Technology Officer
484.59K
+0.08%
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Senior Independent Non-Executive Director
Senior Independent Non-Executive Director
38.91K
+0.88%
Ms. Elizabeth McKee (Liz) Anderson
Ms. Elizabeth McKee (Liz) Anderson
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
+0.87%
Dr. Jeannie Lee
Dr. Jeannie Lee
Independent Non-Executive Director and Scientific & Medical Expert
Independent Non-Executive Director and Scientific & Medical Expert
1.58K
+0.83%
Dr. Harry C. (Hal) Dietz
Dr. Harry C. (Hal) Dietz
Independent Non-Executive Director, Scientific and Medical Expert
Independent Non-Executive Director, Scientific and Medical Expert
--
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
US
5.49B
51.53%
Rest of world
2.71B
25.44%
Europe
2.45B
23.03%
業務
地區
暫無數據
股東統計
更新時間: 8月17日 週日
更新時間: 8月17日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Dodge & Cox
3.88%
Fidelity Management & Research Company LLC
2.54%
Fisher Investments
1.54%
PRIMECAP Management Company
1.37%
JTC Employer Solutions Trusteee Ltd
0.72%
其他
89.96%
持股股東
持股股東
佔比
Dodge & Cox
3.88%
Fidelity Management & Research Company LLC
2.54%
Fisher Investments
1.54%
PRIMECAP Management Company
1.37%
JTC Employer Solutions Trusteee Ltd
0.72%
其他
89.96%
股東類型
持股股東
佔比
Investment Advisor
9.64%
Investment Advisor/Hedge Fund
7.38%
Research Firm
1.05%
Hedge Fund
0.83%
Bank and Trust
0.11%
Individual Investor
0.06%
Pension Fund
0.06%
Insurance Company
0.05%
Family Office
0.03%
其他
80.80%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
1474
388.63M
19.14%
-11.70M
2025Q2
1478
378.08M
18.54%
+5.70M
2025Q1
1494
378.46M
18.50%
+5.08M
2024Q4
1481
355.06M
17.14%
+27.38M
2024Q3
1472
319.97M
15.44%
-30.07M
2024Q2
1585
322.06M
15.54%
-29.11M
2024Q1
1617
318.91M
15.39%
-23.52M
2023Q4
1614
299.81M
14.57%
-35.71M
2023Q3
1570
293.92M
14.35%
-37.46M
2023Q2
1545
286.58M
13.99%
-41.88M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Dodge & Cox
78.76M
3.87%
+106.04K
+0.13%
Jun 30, 2025
Fidelity Management & Research Company LLC
51.48M
2.53%
+872.19K
+1.72%
Jun 30, 2025
Fisher Investments
31.34M
1.54%
+1.31M
+4.35%
Jun 30, 2025
PRIMECAP Management Company
27.73M
1.36%
+2.02M
+7.85%
Jun 30, 2025
JTC Employer Solutions Trusteee Ltd
15.00M
0.74%
-262.98K
-1.72%
Jun 30, 2025
Fidelity Institutional Asset Management
9.53M
0.47%
+10.84K
+0.11%
Jun 30, 2025
T. Rowe Price International Ltd
8.05M
0.4%
+324.11K
+4.20%
Jun 30, 2025
RBC Capital Markets Wealth Management
6.99M
0.34%
+740.61K
+11.84%
Jun 30, 2025
State Street Investment Management (US)
6.71M
0.33%
-258.77K
-3.71%
Jun 30, 2025
Goldman Sachs Asset Management, L.P.
6.12M
0.3%
-2.36M
-27.84%
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
VanEck Pharmaceutical ETF
4.72%
USCF Dividend Income Fund
4.6%
The Opal International Dividend Income ETF
4.11%
Sound Equity Dividend Income ETF
3.49%
Keating Active ETF
3.48%
Brandes International ETF
2.79%
Altrius Global Dividend ETF
2.42%
Fidelity Blue Chip Value ETF
1.52%
Fidelity Women's Leadership ETF
1.17%
Lattice Hartford Mltfctr Dev Mkts (ex-US) Str ETF
1.07%
查看更多
VanEck Pharmaceutical ETF
佔比4.72%
USCF Dividend Income Fund
佔比4.6%
The Opal International Dividend Income ETF
佔比4.11%
Sound Equity Dividend Income ETF
佔比3.49%
Keating Active ETF
佔比3.48%
Brandes International ETF
佔比2.79%
Altrius Global Dividend ETF
佔比2.42%
Fidelity Blue Chip Value ETF
佔比1.52%
Fidelity Women's Leadership ETF
佔比1.17%
Lattice Hartford Mltfctr Dev Mkts (ex-US) Str ETF
佔比1.07%
分紅派息
近5年累計派現
20.79B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Feb 05, 2025
GSK.NB Approximate interim Cash Dividend of gross USD 0.400652 paid on Apr 10, 2025 going ex on Feb 21, 2025
Feb 21, 2025
Apr 10, 2025
Feb 21, 2025
Oct 30, 2024
GSK.NB Final Cash Dividend of gross USD 0.376892 paid on Jan 09, 2025 going ex on Nov 15, 2024
Nov 15, 2024
Jan 09, 2025
Nov 15, 2024
Jul 31, 2024
GSK.NB Interim Cash Dividend of gross USD 0.392813 paid on Oct 10, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Oct 10, 2024
Aug 16, 2024
May 01, 2024
GSK.NB Interim Cash Dividend of gross USD 0.384301 paid on Jul 11, 2024 going ex on May 16, 2024
May 17, 2024
Jul 11, 2024
May 16, 2024
Feb 01, 2024
GSK.NB Interim Cash Dividend of gross USD 0.404885 paid on Apr 11, 2024 going ex on Feb 22, 2024
Feb 23, 2024
Apr 11, 2024
Feb 22, 2024
Nov 01, 2023
GSK.NB Final Cash Dividend of gross USD 0.356356 paid on Jan 11, 2024 going ex on Nov 16, 2023
Nov 17, 2023
Jan 11, 2024
Nov 16, 2023
Jul 26, 2023
GSK.NB Interim Cash Dividend of gross USD 0.343532 paid on Oct 12, 2023 going ex on Aug 17, 2023
Aug 18, 2023
Oct 12, 2023
Aug 17, 2023
Apr 26, 2023
GSK.NB Interim Cash Dividend of gross USD 0.360944 paid on Jul 13, 2023 going ex on May 18, 2023
May 19, 2023
Jul 13, 2023
May 18, 2023
Feb 01, 2023
GSK.NB Interim Cash Dividend of gross USD 0.341883 paid on Apr 13, 2023 going ex on Feb 23, 2023
Feb 24, 2023
Apr 13, 2023
Feb 23, 2023
Nov 02, 2022
GSK.NB Final Cash Dividend of gross USD 0.334785 paid on Jan 12, 2023 going ex on Nov 17, 2022
Nov 18, 2022
Jan 12, 2023
Nov 17, 2022
查看更多
拆合股
公告日期
類型
比率
Jun 24, 2022
Merger
5→4
Jun 24, 2022
Merger
5→4
Jun 24, 2022
Merger
5→4
Jun 24, 2022
Merger
5→4
公告日期
類型
比率
Jun 24, 2022
Merger
5→4
Jun 24, 2022
Merger
5→4
Jun 24, 2022
Merger
5→4
Jun 24, 2022
Merger
5→4
